An expert discusses that while CAR T-cell therapy has transformed the treatment landscape for primary refractory diffuse ...

An expert discusses that this case of a 60-year-old man with primary refractory diffuse large B-cell lymphoma highlights the urgent need for a shift in therapeutic strategy following early relapse ...